Document Detail


Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation.
MedLine Citation:
PMID:  20665855     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Coronary artery disease (CAD) negatively impacts prognosis of patients undergoing surgical aortic valve replacement and revascularization is generally recommended at the time of surgery. Implications of CAD and preprocedural revascularization in the setting of transcatheter aortic valve implantation (TAVI) are not known. METHOD: Patients who underwent successful TAVI from January 2005 to December 2007 were retrospectively divided into five groups according to the extent of CAD assessed with the Duke Myocardial Jeopardy Score: no CAD, CAD with DMJS 0, 2, 4, and > or =6. Study endpoints included 30-day and 1-year survival, evolution of symptoms, left ventricular ejection fraction (LVEF), and mitral regurgitation (MR) and need of revascularization during follow-up. RESULTS: One hundred and thirty-six patients were included, among which 104 (76.5%) had coexisting CAD. Thirty-day mortality in the five study groups was respectively 6.3, 14.6, 7.1, 5.6, and 17.7% with no statistically significant difference between groups (P = 0.56). Overall survival rate at one year was 77.9% (95% CL: 70.9, 84.9) with no difference between groups (P = 0.63). Symptoms, LVEF, and MR all significantly improved in the first month after TAVI, but the extent of improvement did not differ between groups (P > 0.08). Revascularization after TAVI was uncommon. CONCLUSION: The presence of CAD or nonrevascularized myocardium was not associated with an increased risk of adverse events in this initial cohort. On the basis of these early results, complete revascularization may not constitute a prerequisite of TAVI. This conclusion will require re-assessment as experience accrues in patients with extensive CAD.
Authors:
Jean-Bernard Masson; May Lee; Robert H Boone; Abdullah Al Ali; Saad Al Bugami; Jaap Hamburger; G B John Mancini; Jian Ye; Anson Cheung; Karin H Humphries; David Wood; Fabian Nietlispach; John G Webb
Related Documents :
9587865 - Intermediate follow up of the tekna bileaflet valve.
2400265 - Eight years' experience with the medtronic-hall valve prosthesis.
21043705 - Antiplatelet therapy following cardiac valve replacement-a comparative study of aspirin...
20037145 - Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medt...
4042565 - Quality of oral anticoagulant therapy.
17851155 - Carotid endarterectomy under regional analgesia:a retrospective study (1988-1999).
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  76     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  165-73     Citation Subset:  IM    
Copyright Information:
(c) 2010 Wiley-Liss, Inc.
Affiliation:
St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Retinoic Acid Synthesis Promotes Development of Neural Progenitors from Mouse ES Cells by Suppressin...
Next Document:  Transcatheter occlusion of the left atrial appendage-Experimental testing of a new amplatzer device.